The Ser/Thr kinase activity of the Yersinia protein kinase A (YpkA) is necessary for full virulence in the mouse, mollifying phagocytes, and disrupting the eukaryotic cytoskeleton

Microbial Pathogenesis
David J WileyK Schesser

Abstract

The Yersinia protein kinase A (YpkA) is injected into host cells by the yersinial type three secretion system (TTSS). YpkA is widely believed to function within the host cell based on the fact that its kinase domain is clearly homologous to eukaryotic Ser/Thr kinases and that its enzymatic activity, when assayed in vitro, is dependent on eukaryotic-derived host factors. Whether this activity is required for virulence has not been addressed. Here, we report that a Yersinia pseudotuberculosis strain expressing a kinase-inactive YpkA(D270A) variant is greatly attenuated in the mouse model of infection compared to the isogenic wild-type strain. The ypkA(D270A) mutant strain was likewise attenuated in a cell culture infection assay indicating that the kinase activity of YpkA enhances the viability of host cell-associated bacteria. To begin to understand what cellular activities are targeted, we expressed YpkA and its variants in two different yeast model systems. In agreement with previous studies, we found that when rapidly induced and expressed at high levels in Saccharomyces cerevisiae, YpkA-mediated toxicity occurred extremely swiftly. Under these conditions toxicity was dependent on the structurally distinct GTPase-binding doma...Continue Reading

References

Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J B BliskaS Falkow
Apr 1, 1990·Molecular Microbiology·R RosqvistH Wolf-Watz
Jun 3, 1997·Gene·S L Forsburg, D A Sherman
Nov 14, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·B J Hinnebusch
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M AchtmanE Carniel
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·S J JurisJ E Dixon
Aug 22, 2000·The Journal of Biological Chemistry·J M DukuzumuremyiK Schesser
Jul 16, 2002·Infection and Immunity·Nadine GrosdentGuy R Cornelis
Aug 7, 2002·The Journal of Cell Biology·Guy R Cornelis

❮ Previous
Next ❯

Citations

Mar 6, 2012·International Journal of Oral Science·Sarah E Whitmore, Richard J Lamont
Nov 21, 2009·The Journal of Biological Chemistry·Eleanor GrovesEmmanuelle Caron
Nov 30, 2011·The Journal of Experimental Medicine·John SotolongoMasayuki Fukata
Jun 4, 2010·PloS One·Nidhi TyagiNarayanaswamy Srinivasan
Aug 9, 2007·Future Microbiology·Robert R Brubaker
Feb 27, 2008·Current Opinion in Microbiology·Feng Shao
Oct 9, 2007·Trends in Microbiology·Michelle A Laskowski-Arce, Kim Orth
Sep 11, 2007·Journal of Molecular Biology·David J WileyKurt Schesser
Dec 5, 2015·Frontiers in Microbiology·Vaishnavi RavikumarIvan Mijakovic
Jan 8, 2015·Protein Science : a Publication of the Protein Society·Andrey M GrishinMiroslaw Cygler
Dec 18, 2007·Cellular Microbiology·Jennifer E TroskyKim Orth
Oct 27, 2009·Trends in Microbiology·Alain J Cozzone
May 29, 2007·Molecular Cell·Lorena NavarroJack E Dixon
Mar 5, 2015·Nature Structural & Molecular Biology·Roberto Dominguez
Feb 11, 2015·Nature Structural & Molecular Biology·Wei Lin LeeRobert C Robinson
Jan 5, 2017·Scientific Reports·Wei Lin LeeRobert C Robinson
Mar 17, 2016·World Journal of Biological Chemistry·Khavong Pha, Lorena Navarro
Nov 24, 2006·The Journal of Biological Chemistry·Claudia TrasakMartin Aepfelbacher
Feb 21, 2014·The Journal of Biological Chemistry·Marc J Canova, Virginie Molle
Feb 2, 2018·International Neurourology Journal·Whi-An Kwon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.